DrMalick Gibani

Malick Gibani is a Clinical Associate Professor in Bacterial Vaccinology. He completed his medical training at the University of Oxford, after which he continued his clinical training in London. He later joined the Oxford Vaccine Group in the Dept of Paediatrics, University of Oxford, where he undertook a DPhil focusing on Salmonella Typhi and Paratyphi A human challenge models.

Since 2019, he has worked in the Department for Infectious Diseases at Imperial College London. His research interests focus on bacterial vaccines for AMR and pandemic preparedness, including for Salmonella, Klebsiella, Yersinia and Staphylococcus aureus. His particular expertise is in the development of controlled human infection models to accelerate vaccine development and to better understand host-pathogen interactions. 

He is the PI on the Challenge Non-Typhoidal Salmonella (CHANTS) and Protection Against invasive Non-Typhoidal Salmonella projects (PAiNTS), which aims to develop a new controlled human infection model for Salmonella Typhimurium and correlates of immunity. More recently, his work has expanded to make greater use of Controlled Human Infection models across a broader range of research questions, including a growing focus on the role of the gut microbiome in colonisation and host resistance to Salmonella infection

https://www.imperial.ac.uk/infectious-disease/research/human-challenge/chants/